BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marti JH, Grosser N, Thomson DM. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody. Int J Cancer 1976;18:48-57. [PMID: 947860 DOI: 10.1002/ijc.2910180108] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Tan X, Zhao Z, Gao Y, Song Y, Jia Y, Li C. Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre. WJGO 2021;13:531-40. [DOI: 10.4251/wjgo.v13.i7.531] [Reference Citation Analysis]
2 Zhou ZP, Tan XL, Zhao ZM, Gao YX, Song YY, Jia YZ, Li CG. Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre. World J Gastrointest Oncol 2021; 13(7): 706-715 [PMID: 34322199 DOI: 10.4251/wjgo.v13.i7.706] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Evans CM, Bowen JG. Immunological Tests in Carcinoma of the Prostate. Proceedings of the Royal Society of Medicine 2016;70:417-20. [DOI: 10.1177/003591577707000614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Soda K, Kano Y, Nakamura T, Kasono K, Kawakami M, Konishi F. Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J Immunol 2005;175:237-45. [PMID: 15972654 DOI: 10.4049/jimmunol.175.1.237] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
5 Yang TJ, Palker TJ, Harding MW. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma. Cancer Immunol Immunother 1991;33:255-62. [PMID: 2059969 DOI: 10.1007/BF01744945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
6 Meduri F, Doni MG, Merenda R, Bizzarini M, Neri D, Gerunda GE, Maffei Faccioli A. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer. Cancer 1989;64:1103-6. [PMID: 2667748 DOI: 10.1002/1097-0142(19890901)64:5<1103::aid-cncr2820640522>3.0.co;2-c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
7 Juhasz F, Boros P, Szegedi G, Balazs G, Suranyi P, Kraszits E, Stenszky V, Farid NR. Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer 1989;63:1318-26. [PMID: 2784072 DOI: 10.1002/1097-0142(19890401)63:7<1318::aid-cncr2820630716>3.0.co;2-r] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
8 Frankel AE, Boyer CM, Bast RC. Immunobiology of Human Breast Cancer. In: Byers VS, Baldwin RW, editors. Immunology of Malignant Diseases. Dordrecht: Springer Netherlands; 1987. pp. 167-224. [DOI: 10.1007/978-94-009-3219-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
9 Rockwood AP, Mori K, Lamm DL. Serum lymphocyte adherence inhibition test in bladder cancer patients. J Urol 1986;136:1009-12. [PMID: 3773058 DOI: 10.1016/s0022-5347(17)45189-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
10 Mori K, Neal DE Jr, Lamm DL. Immunological assessment of renal cancer patients as evaluated by the lymphocyte adherence inhibition test. J Urol 1986;136:571-5. [PMID: 3525864 DOI: 10.1016/s0022-5347(17)44976-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
11 Mori K, Toshiaki S, Yamagiwa K, Ohkawa T. Mechanism of the LAI test in bladder cancer patients. J Urol 1986;135:856-61. [PMID: 3959218 DOI: 10.1016/s0022-5347(17)45876-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Labateya N, Thomson DM, Reid EC. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant. Eur J Cancer Clin Oncol 1986;22:33-43. [PMID: 3007156 DOI: 10.1016/0277-5379(86)90340-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
13 Thomson DM, Sutherland M, Durko M, Dubois T, Scanzano R, Labateya N, Shenouda G. Purification from a human lung cancer cell line of a water soluble molecule mediating leukocyte adherence inhibition for patients with lung cancer. Int J Cancer 1985;35:707-14. [PMID: 4008098 DOI: 10.1002/ijc.2910350603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Harding MW, Yang TJ. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS). Cancer Immunol Immunother 1985;19:168-76. [PMID: 3891077 DOI: 10.1007/BF00199222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
15 Bhatti R, Ojeda L, Guinan P. Role of Immune Complexes in Tumor Associated Immunity of Patients with Prostatic Cancer. Protides of the Biological Fluids 1985. [DOI: 10.1016/b978-0-08-031739-7.50199-3] [Reference Citation Analysis]
16 Cohen D. The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res 1985;43:75-112. [PMID: 3887857 DOI: 10.1016/s0065-230x(08)60943-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 2.1] [Reference Citation Analysis]
17 Shenouda G, Thomson DM. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer. Cancer Immunol Immunother 1984;18:59-68. [PMID: 6333270 DOI: 10.1007/BF00205401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
18 Shenouda G, Thomson DM. Evidence in advanced cancer of an activated leukocyte state to explain the reversible defect in transmembrane signaling and leukocyte adherence inhibition to extracts of cancer. Clin Immunol Immunopathol 1984;32:212-23. [PMID: 6375921 DOI: 10.1016/0090-1229(84)90122-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
19 Harding MW, Yang TJ. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF). Cell Immunol 1984;87:206-16. [PMID: 6204773 DOI: 10.1016/0008-8749(84)90144-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Prabha B, Kumary, Vasudevan DM. Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity. European Journal of Cancer and Clinical Oncology 1984;20:891-7. [DOI: 10.1016/0277-5379(84)90160-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
21 Morizane T, Sjögren HO. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes. Int J Cancer 1983;31:803-12. [PMID: 6345408 DOI: 10.1002/ijc.2910310622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
22 Morizane T, Sjögren HO. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively. Int J Cancer 1983;31:813-6. [PMID: 6345409 DOI: 10.1002/ijc.2910310623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
23 Dini MM, Lenzi L, Faiferman I. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix. Am J Reprod Immunol (1980) 1983;3:188-90. [PMID: 6881415 DOI: 10.1111/j.1600-0897.1983.tb00244.x] [Reference Citation Analysis]
24 Plain MJ, Whitehead RH, Jose DG. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays. Pathology 1983;15:177-82. [PMID: 6888965 DOI: 10.3109/00313028309084709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
25 Myers WL, Reynolds HA. The early detection of host immune response to spontaneous mouse mammary tumors by leukocyte adherence inhibition. Immunol Lett 1983;7:1-5. [PMID: 6642564 DOI: 10.1016/0165-2478(83)90046-9] [Reference Citation Analysis]
26 Lajzerowicz M, Thomson DM, Reid EC. A study of the immune response to the organ-specific neoantigen of human bladder cancer. J Urol 1982;128:1122-9. [PMID: 6960193 DOI: 10.1016/s0022-5347(17)53358-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
27 Tsang PH, Holland JF, Bekesi JG. Central role of T lymphocytes in specific recognition of tumor antigens in 51Cr-leukocyte adherence inhibition. Cell Immunol 1982;73:365-75. [PMID: 6186404 DOI: 10.1016/0008-8749(82)90463-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
28 Thomson DM, Phelan K, Scanzano R, Fink A. Modulation of antigen-induced leukocyte adherence inhibition by metabolites of arachidonic acid and intracellular nucleotides. Int J Cancer 1982;30:311-9. [PMID: 6752047 DOI: 10.1002/ijc.2910300310] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
29 Thomson DM, Phelan K, Morton DG, Bach MK. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes. Int J Cancer 1982;30:299-306. [PMID: 7129679 DOI: 10.1002/ijc.2910300308] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
30 Dasmahapatra K, Goldrosen MH, Douglass HO Jr. Microplate leukocyte adherence inhibition assay in pancreatic cancer. Effect of chemotherapy on the specific antitumor response. Cancer Lett 1982;16:307-12. [PMID: 6758927 DOI: 10.1016/0304-3835(82)90011-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
31 Haagensen DE. Tumor Markers for Breast Carcinoma. Clinics in Laboratory Medicine 1982;2:543-65. [DOI: 10.1016/s0272-2712(18)31029-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
32 Taylor SG 4th, Safford PC. Antigen specificity of squamous cancers of the head and neck based on tumor site using the slide leukocyte adherence inhibition assay. J Surg Oncol 1982;20:41-5. [PMID: 6176812 DOI: 10.1002/jso.2930200110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
33 Fritze D, Fedra G, Kaufmann M. Prospective evaluation of the leukocyte adherence inhibition (LAI) test in breast cancer using a panel of extracts from known and unknown primary tumors. Int J Cancer 1982;29:261-4. [PMID: 7040260 DOI: 10.1002/ijc.2910290306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
34 Koppi TA, Halliday WJ. Further characterization of the cells involved in leukocyte adherence inhibition with murine tumor extracts. Cell Immunol 1982;66:394-406. [PMID: 6121632 DOI: 10.1016/0008-8749(82)90189-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.2] [Reference Citation Analysis]
35 Bhatti RA, Ablin RJ, Guinan PD. Evaluation of Leukocyte Adherence Inhibition in Prostate Cancer. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50013-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
36 Yonemoto BH. Clinical Application in Breast Cancer. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50009-8] [Reference Citation Analysis]
37 Thomson DMP. The Features of Malignant Melanoma Organ-Specific Neoantigens Recognized by the Antitumor Immune Response of the Human Host. Melanoma Antigens and Antibodies 1982. [DOI: 10.1007/978-1-4684-4079-9_21] [Reference Citation Analysis]
38 Halliday WJ. Specificity of Cell-Mediated Immunoreactivity in Melanoma and Comments on the Nature of Serum Blocking Factors. Melanoma Antigens and Antibodies 1982. [DOI: 10.1007/978-1-4684-4079-9_9] [Reference Citation Analysis]
39 Ritts R, Shani A, Weiland LH, Go VL, Leduc P. Leukocyte Adherence Inhibition, Carcinoembryonic Antigen, and Tumor Size in Patients with Colorectal Carcinoma. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50012-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
40 Sanner T, Kotlar HK. Measurements of Humoral Antitumor Immunity. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50008-6] [Reference Citation Analysis]
41 Holáň V. The Use of the Assay to Measure Immunity in Animal Models. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50010-4] [Reference Citation Analysis]
42 Thomson D. The LAI Response to Human Cancer: The Biology of the LAI Response and Features of the Antigens. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test. Elsevier; 1982. pp. 127-71. [DOI: 10.1016/b978-0-12-689750-0.50011-6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
43 Powell A. Cellular Populations in Leukocyte Adherence Inhibition. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test. Elsevier; 1982. pp. 27-51. [DOI: 10.1016/b978-0-12-689750-0.50007-4] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
44 Mortensen RF. Cellular Requirements for the Leukocyte Adherence Inhibition Response to an Immunogenic Viral Induced Murine Tumor. Assessment of Immune Status by the Leukocyte Adherence Inhibition Test 1982. [DOI: 10.1016/b978-0-12-689750-0.50018-9] [Reference Citation Analysis]
45 Harding MW, Yang TJ. Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma. Int J Cancer 1981;28:361-6. [PMID: 7319678 DOI: 10.1002/ijc.2910280316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
46 Kaneti J, Thomson DM, Reid EC. Prostaglandin E2 affects the tumor immune response in prostatic carcinoma. J Urol 1981;126:65-70. [PMID: 6166761 DOI: 10.1016/s0022-5347(17)54384-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.4] [Reference Citation Analysis]
47 Harding MW, Yang TJ. Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth. Int J Cancer 1981;27:349-55. [PMID: 7026460 DOI: 10.1002/ijc.2910270314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
48 Myers WL, O'Keefe ML. Use of capillary tube leukocyte adherence inhibition for the detection of tumor-specific immune responses. Immunol Commun 1981;10:407-16. [PMID: 6174418 DOI: 10.3109/08820138109050706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
49 Amery WK. Cancer immunotherapy: some critical comments regarding immunological monitoring. Int J Immunopharmacol 1981;3:339-48. [PMID: 7037663 DOI: 10.1016/0192-0561(81)90029-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
50 Russo AJ, Howell JH, Goldrosen MH. Humoral factors involved in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay. Immunol Commun 1981;10:611-30. [PMID: 7037615 DOI: 10.3109/08820138109050714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
51 Kotlar HK, Sanner T. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients. Cancer Lett 1980;11:11-9. [PMID: 7013972 DOI: 10.1016/0304-3835(80)90123-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
52 Winter M, Nelson DS, Milton GW. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma. Aust N Z J Med 1980;10:405-9. [PMID: 7000060 DOI: 10.1111/j.1445-5994.1980.tb04090.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
53 Tsang PH, Tangnavarad K, Lesnick G, Perloff M, Holland JF, Bekesi JG. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma. J Immunol Methods 1980;36:119-35. [PMID: 7000908 DOI: 10.1016/0022-1759(80)90037-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
54 Dunn IS, Halliday WJ. Interactions between T and B lymphocytes and macrophages in the production of leukocyte adherence inhibition factor. Cell Immunol 1980;52:48-61. [PMID: 6156012 DOI: 10.1016/0008-8749(80)90399-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 0.7] [Reference Citation Analysis]
55 Kidd A, Okita N, Row VV, Volpé R. Immunologic aspects of Graves' and Hashimoto's diseases. Metabolism 1980;29:80-99. [PMID: 6986013 DOI: 10.1016/0026-0495(80)90102-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 1.3] [Reference Citation Analysis]
56 Samak R, Israel L, Edelstein R. Influence of tumor burden, tumor removal, immune stimulation, plasmapheresis on monocyte mobilization in cancer patients. Adv Exp Med Biol 1979;121B:411-23. [PMID: 397757 DOI: 10.1007/978-1-4684-8914-9_38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
57 Thomson DM, Tataryn DN, Schwartz R. Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin. Br J Cancer 1980;41:86-99. [PMID: 7362781 DOI: 10.1038/bjc.1980.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
58 Ramey WG, Hashim GA, Fitzpatrick HF. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease. Br J Surg 1979;66:848-52. [PMID: 315807 DOI: 10.1002/bjs.1800661205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
59 Wall JR, Walters BA, Grant C. Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest 1979;2:375-8. [PMID: 583423 DOI: 10.1007/BF03349336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
60 Thomson DM, Tataryn DN, Schwartz R, MacFarlane JK. Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigen. Eur J Cancer (1965) 1979;15:1095-106. [PMID: 393516 DOI: 10.1016/0014-2964(79)90125-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
61 Tataryn DN, MacFarlane JK, Murray D, Thomson DM. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer. Cancer 1979;43:898-912. [PMID: 371789 DOI: 10.1002/1097-0142(197903)43:3<898::aid-cncr2820430318>3.0.co;2-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.5] [Reference Citation Analysis]
62 O'Connor R, MacFarlane JK, Murray D, Thomson DM. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. Br J Cancer 1978;38:674-84. [PMID: 369586 DOI: 10.1038/bjc.1978.272] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.3] [Reference Citation Analysis]
63 Klein TW, Pross SH, Benjamin WR. Characterization of mouse peritoneal exudate and associated leukocyte adherence inhibitory activity after intraperitoneal injection of either Bordetella pertussis or Corynebacterium parvum vaccines. Infect Immun 1978;22:778-85. [PMID: 215552 DOI: 10.1128/iai.22.3.778-785.1978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
64 Lopez M, O'Connor R, MacFarlane JK, Thomson DM. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition. Br J Cancer 1978;38:660-73. [PMID: 369585 DOI: 10.1038/bjc.1978.271] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 0.4] [Reference Citation Analysis]
65 Shani A, Ritts RE Jr, Thynne GS, Weiland LH, Silvers A, Moertel CG, Go VL. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int J Cancer 1978;22:113-9. [PMID: 359486 DOI: 10.1002/ijc.2910220202] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 0.7] [Reference Citation Analysis]
66 Appelboom T, Govaerts A, Wybran J. Leucocyte adherence inhibition test in arthritis. Lancet 1978;2:62-5. [PMID: 78294 DOI: 10.1016/s0140-6736(78)91379-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
67 Wikstrand CJ, Proctor JO, Hartsell SC, Haughton G. Murine Rous-sarcoma-specific immunity detected by leukocyte adherence inhibition: inhibitory effect of normal serum. Int J Cancer 1978;21:639-47. [PMID: 207648 DOI: 10.1002/ijc.2910210515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
68 Tataryn DN, MacFarlane JK, Thomson DM. Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer. Lancet 1978;1:1020-2. [PMID: 76938 DOI: 10.1016/s0140-6736(78)90742-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 0.8] [Reference Citation Analysis]
69 Thomson DM, Rauch JE, Weatherhead JC, Friedlander P, O'Connor R, Grosser N, Shuster J, Gold P. Isolation of human tumour-specific antigens associated with beta2 microglobulin. Br J Cancer 1978;37:753-75. [PMID: 77673 DOI: 10.1038/bjc.1978.114] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 0.7] [Reference Citation Analysis]
70 Cochran AJ. In vitro testing of the immune response. In: Castro JE, editor. Immunological Aspects of Cancer. Dordrecht: Springer Netherlands; 1978. pp. 219-66. [DOI: 10.1007/978-94-010-9418-4_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Shuster J, Thomson DMP, Gold P. Immunodiagnosis. In: Castro JE, editor. Immunological Aspects of Cancer. Dordrecht: Springer Netherlands; 1978. pp. 283-312. [DOI: 10.1007/978-94-010-9418-4_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
72 Silverberg J, Volpé R. Autoimmunity in Endocrine Disease. The Year in Endocrinology 1977 1978. [DOI: 10.1007/978-1-4684-2502-4_11] [Reference Citation Analysis]
73 Lopez MJ, Thomson DM. Isolation of breast cancer tumour antigen from serum and urine. Int J Cancer 1977;20:834-48. [PMID: 73522 DOI: 10.1002/ijc.2910200604] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 0.5] [Reference Citation Analysis]
74 Yamamura Y. Immunologic responses to a murine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors. Int J Cancer 1977;19:717-24. [PMID: 863548 DOI: 10.1002/ijc.2910190518] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
75 Creemers P. The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system. Eur J Immunol 1977;7:48-53. [PMID: 191259 DOI: 10.1002/eji.1830070112] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.5] [Reference Citation Analysis]
76 Grosser N, Marti JH, Proctor JW, Thomson DM. Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell. Int J Cancer 1976;18:39-47. [PMID: 1084863 DOI: 10.1002/ijc.2910180107] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 0.9] [Reference Citation Analysis]
77 Grosser N, Thompson DM. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients. Int J Cancer 1976;18:58-66. [PMID: 59711 DOI: 10.1002/ijc.2910180109] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 1.1] [Reference Citation Analysis]